Search

everythinglearnresearchcommunity

for

Search:↓

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Men's hair loss is not linked to their sex hormone levels, except for lower DHEAS in those with hair loss.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

No clear link between finasteride use and acute pancreatitis risk.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

Dopaminergic therapy in Parkinson's disease patients is linked to increased hair loss.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Hair, skin, and nails supplement use nearly doubled from 2011 to 2020, with higher usage among young adults, females, and certain ethnic groups.

Ethnic Indian women with PCOS often have early symptoms, delayed diagnosis, and need better information and support for treatment and lifestyle management.

Central lipohypertrophy in HIV-infected women may lead to shorter eyelashes.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

Melanoma characteristics vary by age, which could help doctors with diagnosis and prevention.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Men with a family history of hair loss are more likely to experience it themselves, especially if both parents have hair loss.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Scalp melanomas are more dangerous and often missed, needing earlier detection.

Physical activity, height, and smoking affect prostate cancer risk.

Hydroxychloroquine may help delay skin damage in lupus patients.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Different types of female pattern hair loss have unique characteristics and are associated with various health conditions.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

Hispanic women with PCOS are more likely to have liver diseases like NAFLD and NASH.

Low iron levels are linked to more hair loss in non-menopausal women.

Belimumab effectively controls SLE disease activity and reduces steroid use.